Showing results (371-380 of 525) with videos related to
Sort By:
Pageof 53
The Journal of Vascular Access|August 2, 2025
Cephalic vein dilatation at the elbow by preoperative supervised forearm exercise depends on adherence to therapy: Results from the randomized controlled single-blind PINCH trialEsther D Wilschut, Eduard P de Winter, Ernst J Bos, et al.Transplantation Direct|September 21, 2018
Identification and Validation of the Predictive Capacity of Risk Factors and Models in Liver Transplantation Over TimeJoris J Blok, Hein Putter, Herold J Metselaar, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 5, 2007
Improvement of staging by combining tumor and treatment parameters: the value for prognostication in rectal cancerMarleen J E M Gosens, J Han J M van Krieken, Corrie A M Marijnen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Impact of the extent of surgery and postoperative chemoradiotherapy on recurrence patterns in gastric cancerJohan L Dikken, Edwin P M Jansen, Annemieke Cats, et al.Journal of the American College of Cardiology|February 12, 2008
Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention StudyBas L van der Hoeven, Su-San Liem, J Wouter Jukema, et al.Transplantation|February 24, 2015
Thirty Years of Pancreas Transplantation at Leiden University Medical Center: Long-term Follow-up in a Large Eurotransplant CenterWouter H Kopp, Merel J J Verhagen, Joris J Blok, et al.Breast (Edinburgh, Scotland)|August 6, 2026
PREDICT version 3.1 overestimates survival in older women with breast cancer: a population-based external validationJulia N Wolbink, Leti van Bodegom-Vos, Luuk C A Ciere, et al.International Journal of Cancer|January 5, 2020
The prognostic value of the tumor-stroma ratio is most discriminative in patients with grade III or triple-negative breast cancerKiki M H Vangangelt, Andrew R Green, Isabelle M F Heemskerk, et al.European Heart Journal|November 26, 2009
Mortality risk score in primary prevention implantable cardioverter defibrillator recipients with non-ischaemic or ischaemic heart diseaseC Jan Willem Borleffs, Guido H van Welsenes, Rutger J van Bommel, et al.Breast Cancer Research and Treatment|December 13, 2017
Relevant factors for the optimal duration of extended endocrine therapy in early breast cancerErik J Blok, Judith R Kroep, Elma Meershoek-Klein Kranenbarg, et al.Pageof 53